Advertisement
Collaboration › Details
Moderna–Wells Fargo: investor conference, 202109 supply service Moderna presents at Wells Fargo 2021 Virtual Healthcare Conference
Period | 2021-09-10 | |
Partner, 1st | Moderna Inc. (Nasdaq: MRNA) | |
Group | Moderna (Group) | |
Partner, 2nd | Wells Fargo Securities LLC | |
Group | Wells Fargo (Group) | |
Product | Wells Fargo Healthcare Conference 2021 DIGITAL | |
Product 2 | mRNA technology | |
Moderna, Inc.. (9/2/21). "Press Release: Moderna to Present at Upcoming Investor Conferences in September 2021". Cambridge, MA.
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in the following upcoming virtual investor conferences:
> Wells Fargo 2021 Virtual Healthcare Conference on Friday, September 10, 2021 at 10:00 a.m. ET
> Morgan Stanley 19th Annual Global Healthcare Conference on Friday, September 10, 2021 at 11:45 a.m. ET
A live webcast of each presentation will be available under “Events and Presentations” in the Investors section of the Moderna website at investors.modernatx.com. A replay of each webcast will be archived on Moderna’s website for 30 days following the presentation.
About Moderna
In 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the field of messenger RNA (mRNA), to an enterprise with a diverse clinical portfolio of vaccines and therapeutics across six modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna’s capabilities have come together to allow the authorized use of one of the earliest and most-effective vaccines against the COVID-19 pandemic.
Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases. Today, 23 development programs are underway across these therapeutic areas, with 15 programs having entered the clinic. Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit www.modernatx.com.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
Record changed: 2021-09-12 |
Advertisement
More documents for Moderna (Group)
- [1] Caris Life Sciences Inc.. (10/24/23). "Press Release: Caris Life Sciences and Moderna Announce Multi-Year Strategic Partnership to Advance mRNA-Based Oncology Therapeutics". Irving, TX....
- [2] Immatics N.V.. (9/11/23). "Press Release: Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics". Cambridge, MA & Tübingen....
- [3] Alltrna. (10/17/22). "Press Release: Alltrna Appoints Caroline Köhrer, Ph.D., Vice President, Discovery Platform". Cambridge, MA....
- [4] Moderna, Inc.. (8/26/22). "Press Release: Moderna Sues Pfizer and BioNTech for Infringing Patents Central to Moderna's Innovative mRNA Technology Platform". Cambridge, MA....
- [5] Moderna, Inc.. (8/17/22). "Press Release: James Mock Joins Moderna as Chief Financial Officer". Cambridge, MA....
- [6] Moderna, Inc.. (6/21/22). "Press Release: Moderna Announces Plan to Bring mRNA Innovation to the United Kingdom". Cambridge, MA....
- [7] Moderna, Inc.. (4/27/22). "Press Release: Arpa Garay Joins Moderna as Chief Commercial Officer". Cambridge, MA....
- [8] Metagenomi Inc.. (11/2/21). "Press Release: Metagenomi and Moderna Establish Collaboration to Develop Next-Generation In Vivo Gene Editing Therapeutics". Emeryville, CA & Cambirdge, MA....
- [9] Moderna, Inc.. (9/3/21). "Press Release: Moderna Announces Submission of Data to European Medicines Agency for its COVID-19 Vaccine Booster". Cambridge, MA....
- [10] Moderna, Inc.. (9/2/21). "Press Release: Moderna to Present at Upcoming Investor Conferences in September 2021". Cambridge, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top